Peptides, Explained: What They Are, What People Use Them For, and the Regulatory Reality

By Brian Sokalsky, DO, Four Pillars Longevity

Few topics in longevity medicine generate as much interest, and as much noise, as peptides. They show up in podcasts, in gym conversations and in a steady stream of online ads promising faster recovery, easier fat loss and sharper aging. Some of that interest is well founded, and I share a good deal of it. Some of it also gets ahead of the evidence. My goal here is not to sell you on peptides or to talk you out of them. It is to give you a clear, honest picture of what they are, what people actually use them for, and the regulatory reality that anyone considering them should understand first.

What peptides actually are

A peptide is simply a short chain of amino acids, the same building blocks that make up proteins. If you link a lot of them together you get a protein; link a few and you get a peptide. Your body makes thousands of them, and many act as signaling molecules that tell cells what to do. Insulin is a peptide. So are many of the messengers that regulate appetite, growth and repair. In other words, peptides are not exotic or foreign to the body. They are part of its normal language.

Where things get complicated is the leap from that biology to a product you can buy. The word peptide covers an enormous range, from well studied, FDA-approved medications to compounds sold online with almost no human data behind them. Lumping all of that under one word is where most of the confusion, and most of the risk, begins. Peptides are also not the same thing as anabolic steroids, though the two are often confused. They are a different class of molecule entirely.

What people use them for

People are drawn to peptides for a handful of broad reasons. Some are reported to help with tissue repair and recovery from injury or hard training. Others are reported to help with metabolic health and body composition, which is where much of the current popularity sits. Still others are reported to help with sleep, skin and general markers of aging. A few peptides have genuine, well established medical uses, and a much larger group sits in a space where interest and marketing have outpaced rigorous, published evidence in humans.

I want to be careful with that language, and I would encourage you to be too. "Reported to help with" is not the same as "proven to." For many of the peptides being discussed most enthusiastically right now, the human evidence is early, limited or drawn from small studies, and some of the strongest claims rest largely on animal research or anecdote. That does not mean they are worthless. Several are genuinely promising, and this is a field worth watching closely. It means the honest answer to what they actually do is that, in many cases, we do not fully know yet, and that uncertainty deserves to be part of the conversation rather than glossed over.

The regulatory reality

This is the part that gets the least attention in most peptide marketing, and it is the part that matters most. Peptides fall into very different regulatory buckets, and where a given peptide sits should shape how you think about it.

A small number of peptides are FDA-approved medications. They have been through clinical trials, they carry approved labeling, and they are prescribed for defined conditions. At the other end of the spectrum are the many peptides sold as research use only or not for human consumption. Those labels are not a technicality. Products in that category do not have the same level of supervision as FDA-approved medications. So many are not manufactured to pharmaceutical standards, their purity and dosing are not verified, and buying them for personal use means accepting real uncertainty about what is actually in the vial.

In between sits compounding. Under Section 503A of federal law, licensed pharmacies can compound certain medications for individual patients, and the FDA maintains a list of the bulk substances allowed for that purpose. Peptides that are not on that list, or that the agency has flagged, sit on much shakier ground. The FDA has placed a number of widely discussed peptides in what it calls category 2, meaning substances that may present significant safety risks, often citing insufficient human safety data or concerns about impurities and immune reactions.

This is an active, moving area of policy, and it moved recently. On July 23 and 24, 2026, the Pharmacy Compounding Advisory Committee took up seven peptides that had been nominated for the 503A bulks list, the roster of substances licensed pharmacies are permitted to compound for individual patients. The committee voted to recommend six of them for inclusion: BPC-157, KPV, TB-500, MOTS-c, epitalon and semax. It voted against the seventh, emideltide. Those votes went against the recommendation of the FDA review staff, who had argued against inclusion, citing gaps in the available data on characterization, safety and effectiveness.

It is worth being precise about what that vote does and does not do, because much of the marketing that followed it has not been. An advisory committee recommendation is advice, not a rule. It does not add anything to the 503A list, it does not approve any peptide, and it does not make it lawful for a pharmacy to begin compounding these substances today. The FDA itself decides, through formal rulemaking, and that process commonly runs somewhere between one and two years. Nothing about the legal status of any peptide changed in July. What changed is the direction of the conversation, and that is worth following closely.

The practical takeaway is the same one it was before the vote. A peptide being easy to find online, or being spoken about favorably at a public meeting, tells you nothing about whether it is safe, legal to compound, or worth your consideration.

How we think about peptides at Four Pillars

Our approach is deliberately sober. While we are supportive of peptide therapy as a whole (I have used them myself), we treat peptides as one possible tool within a broader plan, never as a shortcut around the fundamentals of nutrition, sleep, movement and mental health that do the heavy lifting for healthspan. We do not chase every trending compound, and we do not treat interest online as evidence.

Just as important is how any peptide therapy would actually work in practice. Four Pillars does not prescribe or dispense medications. Where peptide therapy is appropriate, we work with an online medical practice, Outfit MD, to provide the medical supervision that ensures appropriate safety, quality and dosing, and where necessary, the direct prescribing and monitoring. As mentioned earlier, peptide therapy is only recommended after a real evaluation of your goals, your history and the current evidence and regulatory status. That structure exists precisely because this is a space where quality, sourcing and oversight matter a great deal, and where the online market offers none of them.

The bottom line

Peptides are a legitimate and genuinely promising area of medicine. They are also one of the noisiest and least regulated corners of the wellness world, and both of those things are true at once. If you are curious about them, the right first step is not an online order. It is a conversation grounded in your actual goals and health history, with someone who will be honest about what the evidence does and does not support. If you would like to explore whether peptides make sense for you, the best place to start is a short, no-pressure call.

Book a 15-minute call: https://calendar.app.google/uXha2fLXBmd6LFuo7

This article is for educational purposes and is not medical advice or a substitute for care from a licensed provider. It does not endorse or recommend any specific peptide or product, and it is not an offer to prescribe or dispense. Decisions about your health should be made with a qualified clinician.